BNP/PUT/ALCON AG/80/0.1/20.06.25 Stock

Warrant

DE000PC39BF4

Real-time Boerse Frankfurt Warrants 03:21:01 2024-05-29 EDT
0.72 EUR +5.88% Intraday chart for BNP/PUT/ALCON AG/80/0.1/20.06.25
Current month-44.72%
1 month-43.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-29 0.72 +5.88%
24-05-28 0.68 +6.25%
24-05-27 0.64 -4.48%
24-05-24 0.67 +8.06%
24-05-23 0.62 -1.59%

Real-time Boerse Frankfurt Warrants

Last update May 29, 2024 at 03:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC39BF
ISINDE000PC39BF4
Date issued 2024-01-31
Strike 80 CHF
Maturity 2025-06-20 (388 Days)
Parity 10 : 1
Emission price 1.55
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.84
Lowest since issue 0.61
Spread 0.01
Spread %1.41%

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.77 USD
Average target price
93.44 USD
Spread / Average Target
+5.26%
Consensus